Sign in:
 Email
 Password  save:
  
 Company Reports 
 
 
Membership is free, please Sign Up.
  
My Recent Searches
  Help
  
   
 
 
Get Insiders for : 
Editas Medicine, Inc. (EDIT)  
$5.32 0.24 (4.32%) as of 4:30 Fri 5/10


Download
   
Exchange: N/A
Security Type: N/A
Shares Out: 62,330,000
Market Cap: 331.60(M)
Last Volume: 0 Avg Vol: 0
52 Week Range: $5.035 - $11.47
Level I Sector: N/A
Level II Sector: N/A
Level III Sector: N/A

Member Indexes:
   

Rankings:
     
Insider 3 Months    :   -
Insider 6 Months    :   -
Insider 3/6 Months :   -
Guru Rank Number :  -
Guru Rank Value     :  -
Guru Occurances    :  -

 

            6 Months   1 Year   2 Year  
 
Company Profile   Editas Medicine is a clinical stage genome editing company focused on developing genomic medicines to treat a range of serious diseases. Co. has developed a proprietary genome editing platform based on clustered, regularly interspaced, short palindromic repeats technology and it continues to expand its capabilities. Co. is developing in vivo gene editing medicines, in which the medicine is injected or infused into the patient to edit the cells inside their body, ex vivo gene-edited cell medicines, in which cells collected from a patient are edited with Co.'s technology and then administered back to that same patient, and cellular therapy medicines.

 
 
Summary  (Direct Transactions Only) 3 Months 6 Months 12 Months 24 Months
Total Shares Bought 0 0 0 0
Total Buy Value $0 $0 $0 $0
Total People Bought 0 0 0 0
Total Buy Transactions 0 0 0 0
Total Shares Sold 98,151 98,949 110,942 134,426
Total Sell Value $924,309 $931,137 $1,041,055 $1,277,704
Total People Sold 2 3 3 5
Total Sell Transactions 2 4 11 30
End Date 2024-02-11 2023-11-10 2023-05-12 2022-05-12

   
Records found: 267
  Page 9 of 11  
Filer's Name Relation Title Off-Dir-10% Tran. Date Form Action Price Mkt Value D/I Shares Holdings
Rank

  
3m +/-  
Form
   Bosley Katrine President and CEO   •       •      –    2017-11-01 4 AS $23.37 $196,966 D/D (8,333) 1,391,097     -
   Bosley Katrine President and CEO   •       •      –    2017-10-02 4 AS $24.77 $206,525 D/D (8,333) 1,399,430     -
   Bosley Katrine President and CEO   •       •      –    2017-09-05 4 AS $20.20 $134,681 D/D (6,666) 1,407,763     -
   Bosley Katrine President and CEO   •       •      –    2017-09-01 4 AS $20.40 $204,150 D/D (10,000) 1,414,429     -
   Cole Douglas G. Director   –       •      –    2017-08-17 4 A $0.00 $0 D/D 1,686 3,171     -
   Bosley Katrine President and CEO   •       •      –    2017-08-11 4 AS $20.02 $133,450 D/D (6,666) 1,424,429     -
   Bosley Katrine President and CEO   •       •      –    2017-08-10 4 AS $20.02 $200,160 D/D (10,000) 1,431,095     -
   Cox Gerald Frank Chief Medical Officer   •       –      –    2017-06-02 4 B $14.15 $56,600 D/D 4,000 4,000 2.74     -
   Nikolic Boris Director   –       •      –    2017-06-02 4 B $14.07 $492,527 D/D 35,000 35,000 2.39     -
   Hirsch Andrew Director   –       •      –    2017-05-30 3 IO $0.00 $0 D/D 0 2,000     -
   Bitterman Kevin Director   –       •      –    2017-05-22 4 S $17.00 $17,000,000 I/I (1,000,000) 2,797,144     -
   Glucksmann Alexandra Chief Operating Officer   •       –      –    2017-03-15 4 AS $26.41 $26,410 D/D (1,000) 117,788     -
   Glucksmann Alexandra Chief Operating Officer   •       –      –    2017-03-15 4 OE $0.65 $650 D/D 1,000 118,788     -
   Hack Andrew A. F. Chief Financial Officer   •       –      –    2017-02-15 4 AS $19.20 $57,600 D/D (3,000) 0     -
   Hack Andrew A. F. Chief Financial Officer   •       –      –    2017-02-15 4 OE $3.23 $9,690 D/D 3,000 3,000     -
   Glucksmann Alexandra Chief Operating Officer   •       –      –    2017-02-15 4 AS $20.00 $123,484 D/D (6,000) 117,788     -
   Glucksmann Alexandra Chief Operating Officer   •       –      –    2017-02-15 4 OE $0.65 $3,900 D/D 6,000 123,788     -
   Bitterman Kevin Director   –       •       •   2016-12-07 4 S $15.82 $1,186,500 I/I (75,000) 3,797,144     -
   Polaris Venture Partners Founders Fund Vi, L.p. 10% Owner   –       –       •   2016-12-07 4 S $15.82 $1,186,500 I/I (75,000) 3,797,144     -
   Polaris Venture Partners Founders Fund Vi, L.p. 10% Owner   –       –       •   2016-12-06 4 S $15.87 $793,500 I/I (50,000) 3,872,144     -
   Bitterman Kevin Director   –       •       •   2016-12-06 4 S $15.87 $793,500 I/I (50,000) 3,872,144     -
   Polaris Venture Partners Founders Fund Vi, L.p. 10% Owner   –       –       •   2016-12-05 4 S $15.74 $1,259,200 I/I (80,000) 3,922,144     -
   Bitterman Kevin Director   –       •       •   2016-12-05 4 S $15.74 $1,259,200 I/I (80,000) 3,922,144     -
   Bitterman Kevin Director   –       •       •   2016-11-23 4 S $15.71 $337,451 I/I (21,480) 4,002,144     -
   Polaris Venture Partners Founders Fund Vi, L.p. 10% Owner   –       –       •   2016-11-23 4 S $15.71 $337,451 I/I (21,480) 4,002,144     -
  267 Records found
  1  2  3  4  5  6  7  8  9  Next   
  Page 9 of 11
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
  OE - Options Exercised A - Acquired
  IO - Initital Ownership D - Disposed
 
 
    Copyright © 2024 j3sg.com | Disclaimer & Terms of use          Products & Service  About Us  Contact Us